Buy BPC-157 2026 — Pentadecapeptide for Angiogenesis & Tissue Model Research (EU)
BPC-157 at a glance
| Designation | BPC-157 (Pentadecapeptide) |
|---|---|
| Identity | Synthetic peptide of 15 amino acids, subsequence of a protein described in gastric juice |
| Synonyms | Pentadecapeptide, PL 14736, Body Protection Compound |
| Research context | Angiogenesis/Vascular Models, Nitric Oxide (NO) System, Growth Factor and Tendon/Tissue Cell Models (in vitro/animal model) |
| CAS number | 137525-51-0 (the batch-specific COA is authoritative) |
| Molecular formula | C₆₂H₉₈N₁₆O₂₂ (the batch-specific COA is authoritative) |
| Form | Lyophilised powder (freeze-dried), sealed vial |
| Amount | 10 mg per vial |
| Purity | ≥99% (HPLC), identity confirmed by LC-MS |
| Analysis | External third-party laboratory, batch-specific COA |
| Intended use | For Research Use Only (RUO) |
| Price | €49.90 · Shipping from Germany |
What is BPC-157?
BPC-157 is a synthetic pentadecapeptide – that is, a peptide of 15 amino acids. The abbreviation BPC stands for "Body Protection Compound"; the substance also appears in the literature under the designations PL 14736 and simply „Pentadecapeptide“. The sequence corresponds to a subsequence of a protein described in gastric juice, but was produced entirely synthetically for research purposes. BPC-157 is supplied as a stable lyophilisate in a sealed vial (10 mg). In laboratory research, it serves as a well-characterised reference substance; the CAS number and molecular formula are also documented in the batch-specific certificate of analysis.
Molecular profile & target structure
BPC-157 consists of a defined chain of 15 amino acids (molecular formula C₆₂H₉₈N₁₆O₂₂, CAS 137525-51-0). As a fully synthetic peptide, it can be characterised with analytical clarity – the molecular mass is unambiguously determinable via LC-MS, and purity quantifiable via HPLC. In the preclinical literature, BPC-157 is frequently used as a stable model peptide drawn upon, as it is comparatively robust under laboratory conditions and can be synthesised with good reproducibility. The combination of a defined sequence and good analytical characterisability makes the pentadecapeptide complex a recurring reference in vascular, tissue and cell biological study models.
What in-vitro and animal model studies document
The following summary reflects only what is described in the publicly accessible preclinical literature – it is not a statement about an effect or suitability in humans.
- Angiogenesis and vascular models: Published in-vitro and animal model studies investigate BPC-157 in relation to angiogenesis processes and vascular structures in experimental models.
- Nitric oxide (NO) system: Several papers document observations on BPC-157 in the context of the NO system in preclinical models.
- Growth Factor Models: Individual studies describe investigations of BPC-157 in connection with growth factors in cultured cells.
- Tendon and tissue cell models: Preclinical studies investigate BPC-157 in tendon and tissue cell models.
These observations originate from in-vitro and animal models. They provide the basis for research interest in BPC-157, but do not indicate anything about its safety, efficacy, or any application outside of laboratory research.
Purity, COA & Analytical Testing
Purity and identity are the two values that count. HPLC demonstrates purity (target value ≥ 99 %), LC-MS confirms the identity via molecular mass. Both values are listed on the batch-related COA. We explain how to read such a certificate in Understanding and reading a Certificate of Analysis (COA); the procedures themselves in Peptide Purity: HPLC and LC-MS Explained.
Storage & Handling
As a lyophilisate, BPC-157 is stable when stored is kept cool, dry and protected from light and stored – ideally at -20°C for longer storage. Please refer to the COA for batch-specific information. Principles: Storing and Handling Research Peptides.
Buying BPC-157 in the EU – what matters
What matters is not the price, but this: Does the label match the contents? Here's what BlitzLab delivers on:
- Batch-specific COA from a third-party laboratory – HPLC (purity) and LC-MS (identity), carried out externally, not by us.
- EU Shipping, discreetly packaged, with tracking – usually 2–5 working days.
- Transparent RUO stance – clear labelling, complete Compliance page, no claims of efficacy or cure.
What else to look out for with a reputable provider: 7-point checklist.
Frequently asked questions about buying BPC-157
Note on Sources & RUO
This guide summarises publicly available preclinical research literature (in vitro and animal models) on BPC-157. The accompanying certificate of analysis is always decisive for the identity, CAS number, molecular formula and purity of the supplied batch. All information is for informational purposes within the research context (Research Use Only) and does not constitute medical advice, dosage or application recommendations.
Certificate of Analysis, specification, and availability directly on the product page.